Taoro-Gonzalez et al. [19] showed that increased IL-1β levels play a main role in altering glutamatergic neurotransmission in the hippocampus and in inducing cognitive impairment, which may be reversed by blocking the IL-1 receptor. The gene discussed is IL1B; the disease is Cognitive impairment.